Drug information for MOXIFLOXACIN HYDROCHLORIDE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
SOLUTION; OPHTHALMIC 0.5% Tentative Approval   MOXIFLOXACIN HYDROCHLORIDE moxifloxacin TEVA PHARMS 78073
SOLUTION; OPHTHALMIC 0.5% Tentative Approval   MOXIFLOXACIN HYDROCHLORIDE moxifloxacin APOTEX INC 90080
TABLET; ORAL 400MG Tentative Approval   MOXIFLOXACIN HYDROCHLORIDE moxifloxacin TORRENT PHARMS LTD 200160
TABLET; ORAL 400MG Tentative Approval  (Reference Drug) MOXIFLOXACIN HYDROCHLORIDE moxifloxacin DR REDDYS LABS LTD 76938
TABLET; ORAL 400MG Tentative Approval   MOXIFLOXACIN HYDROCHLORIDE moxifloxacin TEVA PHARMS 77437

Drug Adverse Effects information for MOXIFLOXACIN HYDROCHLORIDE

Role code Indications Reaction # Reports
SS INFECTION CYTOLYTIC HEPATITIS 1
SS INFECTION PSEUDOMONAS INFECTION 1
SS INFECTION SUPERINFECTION 1
SS LEGIONELLA INFECTION CYTOLYTIC HEPATITIS 2
SS LEGIONELLA INFECTION PSEUDOMONAS INFECTION 2
SS LEGIONELLA INFECTION SUPERINFECTION 2
SS PRODUCT USED FOR UNKNOWN INDICATION BLOOD MAGNESIUM DECREASED 3
SS PRODUCT USED FOR UNKNOWN INDICATION CYTOLYTIC HEPATITIS 10
SS PRODUCT USED FOR UNKNOWN INDICATION ELECTROCARDIOGRAM QT PROLONGED 3
SS PRODUCT USED FOR UNKNOWN INDICATION ELECTROCARDIOGRAM T WAVE ABNORMAL 3
SS PRODUCT USED FOR UNKNOWN INDICATION LOSS OF CONSCIOUSNESS 3
SS PRODUCT USED FOR UNKNOWN INDICATION PSEUDOMONAS INFECTION 10
SS PRODUCT USED FOR UNKNOWN INDICATION RESPIRATORY TRACT INFECTION 3
SS PRODUCT USED FOR UNKNOWN INDICATION SUPERINFECTION 10
SS PRODUCT USED FOR UNKNOWN INDICATION VENTRICULAR TACHYCARDIA 3
SS STAPHYLOCOCCAL INFECTION CYTOLYTIC HEPATITIS 1
SS STAPHYLOCOCCAL INFECTION PSEUDOMONAS INFECTION 1
SS STAPHYLOCOCCAL INFECTION SUPERINFECTION 1
SS SUPERINFECTION CYTOLYTIC HEPATITIS 1
SS SUPERINFECTION PSEUDOMONAS INFECTION 1
SS SUPERINFECTION SUPERINFECTION 1
C AGE-RELATED MACULAR DEGENERATION CEREBRAL INFARCTION 1
C ANTIBIOTIC PROPHYLAXIS ABDOMINAL DISCOMFORT 2
C ANTIBIOTIC PROPHYLAXIS BLOOD GLUCOSE INCREASED 2
C ANTIBIOTIC PROPHYLAXIS DIARRHOEA 2
C ANTIBIOTIC PROPHYLAXIS DIFFUSE LARGE B-CELL LYMPHOMA 2
C ANTIBIOTIC PROPHYLAXIS DISSEMINATED INTRAVASCULAR COAGULATION 2
C ANTIBIOTIC PROPHYLAXIS EPISTAXIS 2
C ANTIBIOTIC PROPHYLAXIS EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2
C ANTIBIOTIC PROPHYLAXIS GRAFT VERSUS HOST DISEASE IN SKIN 2
C ANTIBIOTIC PROPHYLAXIS ORAL HERPES 2
C ANTIBIOTIC PROPHYLAXIS PLEURISY 2
C ANTIBIOTIC PROPHYLAXIS PNEUMONIA 2
C ANTIBIOTIC PROPHYLAXIS PRURITUS 2
C ANTIBIOTIC PROPHYLAXIS PYREXIA 2
C ANTIBIOTIC PROPHYLAXIS RENAL FAILURE ACUTE 2
C ANTIBIOTIC PROPHYLAXIS STAPHYLOCOCCAL SEPSIS 2
C ANTIBIOTIC PROPHYLAXIS STEVENS-JOHNSON SYNDROME 2
C ANTIBIOTIC PROPHYLAXIS VOMITING 2
C ANTIBIOTIC PROPHYLAXIS WHITE BLOOD CELL COUNT DECREASED 2
C ANTIFUNGAL PROPHYLAXIS ABDOMINAL DISCOMFORT 1
C ANTIFUNGAL PROPHYLAXIS BLOOD GLUCOSE INCREASED 1
C ANTIFUNGAL PROPHYLAXIS DIARRHOEA 1
C ANTIFUNGAL PROPHYLAXIS DIFFUSE LARGE B-CELL LYMPHOMA 1
C ANTIFUNGAL PROPHYLAXIS DISSEMINATED INTRAVASCULAR COAGULATION 1
C ANTIFUNGAL PROPHYLAXIS EPISTAXIS 1
C ANTIFUNGAL PROPHYLAXIS EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1
C ANTIFUNGAL PROPHYLAXIS GRAFT VERSUS HOST DISEASE IN SKIN 1
C ANTIFUNGAL PROPHYLAXIS ORAL HERPES 1
C ANTIFUNGAL PROPHYLAXIS PLEURISY 1
C ANTIFUNGAL PROPHYLAXIS PNEUMONIA 1
C ANTIFUNGAL PROPHYLAXIS PRURITUS 1
C ANTIFUNGAL PROPHYLAXIS PYREXIA 1
C ANTIFUNGAL PROPHYLAXIS RENAL FAILURE ACUTE 1
C ANTIFUNGAL PROPHYLAXIS STAPHYLOCOCCAL SEPSIS 1
C ANTIFUNGAL PROPHYLAXIS STEVENS-JOHNSON SYNDROME 1
C ANTIFUNGAL PROPHYLAXIS VOMITING 1
C ANTIFUNGAL PROPHYLAXIS WHITE BLOOD CELL COUNT DECREASED 1
C ANTIVIRAL PROPHYLAXIS ABDOMINAL DISCOMFORT 2
C ANTIVIRAL PROPHYLAXIS BLOOD GLUCOSE INCREASED 2
C ANTIVIRAL PROPHYLAXIS DIARRHOEA 2
C ANTIVIRAL PROPHYLAXIS DIFFUSE LARGE B-CELL LYMPHOMA 2
C ANTIVIRAL PROPHYLAXIS DISSEMINATED INTRAVASCULAR COAGULATION 2
C ANTIVIRAL PROPHYLAXIS EPISTAXIS 2
C ANTIVIRAL PROPHYLAXIS EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2
C ANTIVIRAL PROPHYLAXIS GRAFT VERSUS HOST DISEASE IN SKIN 2
C ANTIVIRAL PROPHYLAXIS ORAL HERPES 2
C ANTIVIRAL PROPHYLAXIS PLEURISY 2
C ANTIVIRAL PROPHYLAXIS PNEUMONIA 2
C ANTIVIRAL PROPHYLAXIS PRURITUS 2
C ANTIVIRAL PROPHYLAXIS PYREXIA 2
C ANTIVIRAL PROPHYLAXIS RENAL FAILURE ACUTE 2
C ANTIVIRAL PROPHYLAXIS STAPHYLOCOCCAL SEPSIS 2
C ANTIVIRAL PROPHYLAXIS STEVENS-JOHNSON SYNDROME 2
C ANTIVIRAL PROPHYLAXIS VOMITING 2
C ANTIVIRAL PROPHYLAXIS WHITE BLOOD CELL COUNT DECREASED 2
C APLASTIC ANAEMIA ABDOMINAL DISCOMFORT 2
C APLASTIC ANAEMIA BLOOD GLUCOSE INCREASED 2
C APLASTIC ANAEMIA DIARRHOEA 2
C APLASTIC ANAEMIA DIFFUSE LARGE B-CELL LYMPHOMA 2
C APLASTIC ANAEMIA DISSEMINATED INTRAVASCULAR COAGULATION 2
C APLASTIC ANAEMIA EPISTAXIS 2
C APLASTIC ANAEMIA EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2
C APLASTIC ANAEMIA GRAFT VERSUS HOST DISEASE IN SKIN 2
C APLASTIC ANAEMIA ORAL HERPES 2
C APLASTIC ANAEMIA PLEURISY 2
C APLASTIC ANAEMIA PNEUMONIA 2
C APLASTIC ANAEMIA PRURITUS 2
C APLASTIC ANAEMIA PYREXIA 2
C APLASTIC ANAEMIA RENAL FAILURE ACUTE 2
C APLASTIC ANAEMIA STAPHYLOCOCCAL SEPSIS 2
C APLASTIC ANAEMIA STEVENS-JOHNSON SYNDROME 2
C APLASTIC ANAEMIA VOMITING 2
C APLASTIC ANAEMIA WHITE BLOOD CELL COUNT DECREASED 2
C BONE MARROW CONDITIONING REGIMEN ABDOMINAL DISCOMFORT 6
C BONE MARROW CONDITIONING REGIMEN BLOOD GLUCOSE INCREASED 6
C BONE MARROW CONDITIONING REGIMEN DIARRHOEA 6
C BONE MARROW CONDITIONING REGIMEN DIFFUSE LARGE B-CELL LYMPHOMA 6
C BONE MARROW CONDITIONING REGIMEN DISSEMINATED INTRAVASCULAR COAGULATION 6
C BONE MARROW CONDITIONING REGIMEN EPISTAXIS 6
C BONE MARROW CONDITIONING REGIMEN EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 6
C BONE MARROW CONDITIONING REGIMEN GRAFT VERSUS HOST DISEASE IN SKIN 6
C BONE MARROW CONDITIONING REGIMEN ORAL HERPES 6
C BONE MARROW CONDITIONING REGIMEN PLEURISY 6
C BONE MARROW CONDITIONING REGIMEN PNEUMONIA 6
C BONE MARROW CONDITIONING REGIMEN PRURITUS 6
C BONE MARROW CONDITIONING REGIMEN PYREXIA 6
C BONE MARROW CONDITIONING REGIMEN RENAL FAILURE ACUTE 6
C BONE MARROW CONDITIONING REGIMEN STAPHYLOCOCCAL SEPSIS 6
C BONE MARROW CONDITIONING REGIMEN STEVENS-JOHNSON SYNDROME 6
C BONE MARROW CONDITIONING REGIMEN VOMITING 6
C BONE MARROW CONDITIONING REGIMEN WHITE BLOOD CELL COUNT DECREASED 6
C CONSTIPATION PROPHYLAXIS ABDOMINAL DISCOMFORT 1
C CONSTIPATION PROPHYLAXIS BLOOD GLUCOSE INCREASED 1
C CONSTIPATION PROPHYLAXIS DIARRHOEA 1
C CONSTIPATION PROPHYLAXIS DIFFUSE LARGE B-CELL LYMPHOMA 1
C CONSTIPATION PROPHYLAXIS DISSEMINATED INTRAVASCULAR COAGULATION 1
C CONSTIPATION PROPHYLAXIS EPISTAXIS 1
C CONSTIPATION PROPHYLAXIS EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1
C CONSTIPATION PROPHYLAXIS GRAFT VERSUS HOST DISEASE IN SKIN 1
C CONSTIPATION PROPHYLAXIS ORAL HERPES 1
C CONSTIPATION PROPHYLAXIS PLEURISY 1
C CONSTIPATION PROPHYLAXIS PNEUMONIA 1
C CONSTIPATION PROPHYLAXIS PRURITUS 1
C CONSTIPATION PROPHYLAXIS PYREXIA 1
C CONSTIPATION PROPHYLAXIS RENAL FAILURE ACUTE 1
C CONSTIPATION PROPHYLAXIS STAPHYLOCOCCAL SEPSIS 1
C CONSTIPATION PROPHYLAXIS STEVENS-JOHNSON SYNDROME 1
C CONSTIPATION PROPHYLAXIS VOMITING 1
C CONSTIPATION PROPHYLAXIS WHITE BLOOD CELL COUNT DECREASED 1
C ENDOTRACHEAL INTUBATION ABDOMINAL DISCOMFORT 3
C ENDOTRACHEAL INTUBATION BLOOD GLUCOSE INCREASED 3
C ENDOTRACHEAL INTUBATION DIARRHOEA 3
C ENDOTRACHEAL INTUBATION DIFFUSE LARGE B-CELL LYMPHOMA 3
C ENDOTRACHEAL INTUBATION DISSEMINATED INTRAVASCULAR COAGULATION 3
C ENDOTRACHEAL INTUBATION EPISTAXIS 3
C ENDOTRACHEAL INTUBATION EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 3
C ENDOTRACHEAL INTUBATION GRAFT VERSUS HOST DISEASE IN SKIN 3
C ENDOTRACHEAL INTUBATION ORAL HERPES 3
C ENDOTRACHEAL INTUBATION PLEURISY 3
C ENDOTRACHEAL INTUBATION PNEUMONIA 3
C ENDOTRACHEAL INTUBATION PRURITUS 3
C ENDOTRACHEAL INTUBATION PYREXIA 3
C ENDOTRACHEAL INTUBATION RENAL FAILURE ACUTE 3
C ENDOTRACHEAL INTUBATION STAPHYLOCOCCAL SEPSIS 3
C ENDOTRACHEAL INTUBATION STEVENS-JOHNSON SYNDROME 3
C ENDOTRACHEAL INTUBATION VOMITING 3
C ENDOTRACHEAL INTUBATION WHITE BLOOD CELL COUNT DECREASED 3
C GASTRITIS PROPHYLAXIS ABDOMINAL DISCOMFORT 4
C GASTRITIS PROPHYLAXIS BLOOD GLUCOSE INCREASED 4
C GASTRITIS PROPHYLAXIS DIARRHOEA 4
C GASTRITIS PROPHYLAXIS DIFFUSE LARGE B-CELL LYMPHOMA 4
C GASTRITIS PROPHYLAXIS DISSEMINATED INTRAVASCULAR COAGULATION 4
C GASTRITIS PROPHYLAXIS EPISTAXIS 4
C GASTRITIS PROPHYLAXIS EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 4
C GASTRITIS PROPHYLAXIS GRAFT VERSUS HOST DISEASE IN SKIN 4
C GASTRITIS PROPHYLAXIS ORAL HERPES 4
C GASTRITIS PROPHYLAXIS PLEURISY 4
C GASTRITIS PROPHYLAXIS PNEUMONIA 4
C GASTRITIS PROPHYLAXIS PRURITUS 4
C GASTRITIS PROPHYLAXIS PYREXIA 4
C GASTRITIS PROPHYLAXIS RENAL FAILURE ACUTE 4
C GASTRITIS PROPHYLAXIS STAPHYLOCOCCAL SEPSIS 4
C GASTRITIS PROPHYLAXIS STEVENS-JOHNSON SYNDROME 4
C GASTRITIS PROPHYLAXIS VOMITING 4
C GASTRITIS PROPHYLAXIS WHITE BLOOD CELL COUNT DECREASED 4
C HIV INFECTION CYTOLYTIC HEPATITIS 1
C HIV INFECTION DRUG INTOLERANCE 1
C HIV INFECTION ENTEROCOCCUS TEST POSITIVE 1
C HIV INFECTION HEPATIC ARTERY THROMBOSIS 1
C HIV INFECTION HEPATIC NECROSIS 1
C HIV INFECTION HEPATITIS FULMINANT 1
C HIV INFECTION LIVER TRANSPLANT 1
C HIV INFECTION PERITONEAL HAEMORRHAGE 1
C HIV INFECTION PERITONITIS BACTERIAL 1
C HIV INFECTION PYREXIA 1
C HIV INFECTION STAPHYLOCOCCAL INFECTION 1
C HYPERKALAEMIA BLOOD PRESSURE DECREASED 1
C HYPERKALAEMIA CHILLS 1
C HYPERKALAEMIA PHLEBITIS 1
C HYPERKALAEMIA PYREXIA 1
C HYPERTENSION BLOOD PRESSURE DECREASED 1
C HYPERTENSION CHILLS 1
C HYPERTENSION PHLEBITIS 1
C HYPERTENSION PYREXIA 1
C HYPERURICAEMIA BLOOD PRESSURE DECREASED 1
C HYPERURICAEMIA CHILLS 1
C HYPERURICAEMIA PHLEBITIS 1
C HYPERURICAEMIA PYREXIA 1
C INFECTION PROPHYLAXIS ABDOMINAL DISCOMFORT 1
C INFECTION PROPHYLAXIS BLOOD GLUCOSE INCREASED 1
C INFECTION PROPHYLAXIS DIARRHOEA 1
C INFECTION PROPHYLAXIS DIFFUSE LARGE B-CELL LYMPHOMA 1
C INFECTION PROPHYLAXIS DISSEMINATED INTRAVASCULAR COAGULATION 1
C INFECTION PROPHYLAXIS EPISTAXIS 1
C INFECTION PROPHYLAXIS EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1
C INFECTION PROPHYLAXIS GRAFT VERSUS HOST DISEASE IN SKIN 1
C INFECTION PROPHYLAXIS ORAL HERPES 1
C INFECTION PROPHYLAXIS PLEURISY 1
C INFECTION PROPHYLAXIS PNEUMONIA 1
C INFECTION PROPHYLAXIS PRURITUS 1
C INFECTION PROPHYLAXIS PYREXIA 1
C INFECTION PROPHYLAXIS RENAL FAILURE ACUTE 1
C INFECTION PROPHYLAXIS STAPHYLOCOCCAL SEPSIS 1
C INFECTION PROPHYLAXIS STEVENS-JOHNSON SYNDROME 1
C INFECTION PROPHYLAXIS VOMITING 1
C INFECTION PROPHYLAXIS WHITE BLOOD CELL COUNT DECREASED 1
C KIDNEY TRANSPLANT REJECTION BLOOD PRESSURE DECREASED 4
C KIDNEY TRANSPLANT REJECTION CHILLS 4
C KIDNEY TRANSPLANT REJECTION PHLEBITIS 4
C KIDNEY TRANSPLANT REJECTION PYREXIA 4
C MULTIPLE SCLEROSIS BLISTER 1
C MULTIPLE SCLEROSIS INJECTION SITE INFLAMMATION 1
C MULTIPLE SCLEROSIS INJECTION SITE NECROSIS 1
C PREMEDICATION ABDOMINAL DISCOMFORT 4
C PREMEDICATION BLOOD GLUCOSE INCREASED 4
C PREMEDICATION DIARRHOEA 4
C PREMEDICATION DIFFUSE LARGE B-CELL LYMPHOMA 4
C PREMEDICATION DISSEMINATED INTRAVASCULAR COAGULATION 4
C PREMEDICATION EPISTAXIS 4
C PREMEDICATION EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 4
C PREMEDICATION GRAFT VERSUS HOST DISEASE IN SKIN 4
C PREMEDICATION ORAL HERPES 4
C PREMEDICATION PLEURISY 4
C PREMEDICATION PNEUMONIA 4
C PREMEDICATION PRURITUS 4
C PREMEDICATION PYREXIA 4
C PREMEDICATION RENAL FAILURE ACUTE 4
C PREMEDICATION STAPHYLOCOCCAL SEPSIS 4
C PREMEDICATION STEVENS-JOHNSON SYNDROME 4
C PREMEDICATION VOMITING 4
C PREMEDICATION WHITE BLOOD CELL COUNT DECREASED 4
C PRODUCT USED FOR UNKNOWN INDICATION BLOOD PRESSURE DECREASED 4
C PRODUCT USED FOR UNKNOWN INDICATION CHILLS 4
C PRODUCT USED FOR UNKNOWN INDICATION PHLEBITIS 4
C PRODUCT USED FOR UNKNOWN INDICATION PYREXIA 4
C PROPHYLAXIS ABDOMINAL DISCOMFORT 8
C PROPHYLAXIS BLOOD GLUCOSE INCREASED 8
C PROPHYLAXIS BLOOD PRESSURE DECREASED 1
C PROPHYLAXIS CHILLS 1
C PROPHYLAXIS DIARRHOEA 8
C PROPHYLAXIS DIFFUSE LARGE B-CELL LYMPHOMA 8
C PROPHYLAXIS DISSEMINATED INTRAVASCULAR COAGULATION 8
C PROPHYLAXIS EPISTAXIS 8
C PROPHYLAXIS EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 8
C PROPHYLAXIS GRAFT VERSUS HOST DISEASE IN SKIN 8
C PROPHYLAXIS ORAL HERPES 8
C PROPHYLAXIS PHLEBITIS 1
C PROPHYLAXIS PLEURISY 8
C PROPHYLAXIS PNEUMONIA 8
C PROPHYLAXIS PRURITUS 8
C PROPHYLAXIS PYREXIA 9
C PROPHYLAXIS RENAL FAILURE ACUTE 8
C PROPHYLAXIS STAPHYLOCOCCAL SEPSIS 8
C PROPHYLAXIS STEVENS-JOHNSON SYNDROME 8
C PROPHYLAXIS VOMITING 8
C PROPHYLAXIS WHITE BLOOD CELL COUNT DECREASED 8
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE ABDOMINAL DISCOMFORT 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE BLOOD GLUCOSE INCREASED 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE DIARRHOEA 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE DIFFUSE LARGE B-CELL LYMPHOMA 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE DISSEMINATED INTRAVASCULAR COAGULATION 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE EPISTAXIS 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE GRAFT VERSUS HOST DISEASE IN SKIN 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE ORAL HERPES 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE PLEURISY 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE PNEUMONIA 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE PRURITUS 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE PYREXIA 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE RENAL FAILURE ACUTE 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE STAPHYLOCOCCAL SEPSIS 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE STEVENS-JOHNSON SYNDROME 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE VOMITING 2
C PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE WHITE BLOOD CELL COUNT DECREASED 2
C PROPHYLAXIS OF NAUSEA AND VOMITING ABDOMINAL DISCOMFORT 2
C PROPHYLAXIS OF NAUSEA AND VOMITING BLOOD GLUCOSE INCREASED 2
C PROPHYLAXIS OF NAUSEA AND VOMITING DIARRHOEA 2
C PROPHYLAXIS OF NAUSEA AND VOMITING DIFFUSE LARGE B-CELL LYMPHOMA 2
C PROPHYLAXIS OF NAUSEA AND VOMITING DISSEMINATED INTRAVASCULAR COAGULATION 2
C PROPHYLAXIS OF NAUSEA AND VOMITING EPISTAXIS 2
C PROPHYLAXIS OF NAUSEA AND VOMITING EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2
C PROPHYLAXIS OF NAUSEA AND VOMITING GRAFT VERSUS HOST DISEASE IN SKIN 2
C PROPHYLAXIS OF NAUSEA AND VOMITING ORAL HERPES 2
C PROPHYLAXIS OF NAUSEA AND VOMITING PLEURISY 2
C PROPHYLAXIS OF NAUSEA AND VOMITING PNEUMONIA 2
C PROPHYLAXIS OF NAUSEA AND VOMITING PRURITUS 2
C PROPHYLAXIS OF NAUSEA AND VOMITING PYREXIA 2
C PROPHYLAXIS OF NAUSEA AND VOMITING RENAL FAILURE ACUTE 2
C PROPHYLAXIS OF NAUSEA AND VOMITING STAPHYLOCOCCAL SEPSIS 2
C PROPHYLAXIS OF NAUSEA AND VOMITING STEVENS-JOHNSON SYNDROME 2
C PROPHYLAXIS OF NAUSEA AND VOMITING VOMITING 2
C PROPHYLAXIS OF NAUSEA AND VOMITING WHITE BLOOD CELL COUNT DECREASED 2
C RENAL IMPAIRMENT ABDOMINAL DISCOMFORT 1
C RENAL IMPAIRMENT BLOOD GLUCOSE INCREASED 1
C RENAL IMPAIRMENT DIARRHOEA 1
C RENAL IMPAIRMENT DIFFUSE LARGE B-CELL LYMPHOMA 1
C RENAL IMPAIRMENT DISSEMINATED INTRAVASCULAR COAGULATION 1
C RENAL IMPAIRMENT EPISTAXIS 1
C RENAL IMPAIRMENT EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1
C RENAL IMPAIRMENT GRAFT VERSUS HOST DISEASE IN SKIN 1
C RENAL IMPAIRMENT ORAL HERPES 1
C RENAL IMPAIRMENT PLEURISY 1
C RENAL IMPAIRMENT PNEUMONIA 1
C RENAL IMPAIRMENT PRURITUS 1
C RENAL IMPAIRMENT PYREXIA 1
C RENAL IMPAIRMENT RENAL FAILURE ACUTE 1
C RENAL IMPAIRMENT STAPHYLOCOCCAL SEPSIS 1
C RENAL IMPAIRMENT STEVENS-JOHNSON SYNDROME 1
C RENAL IMPAIRMENT VOMITING 1
C RENAL IMPAIRMENT WHITE BLOOD CELL COUNT DECREASED 1
C SEDATIVE THERAPY ABDOMINAL DISCOMFORT 2
C SEDATIVE THERAPY BLOOD GLUCOSE INCREASED 2
C SEDATIVE THERAPY DIARRHOEA 2
C SEDATIVE THERAPY DIFFUSE LARGE B-CELL LYMPHOMA 2
C SEDATIVE THERAPY DISSEMINATED INTRAVASCULAR COAGULATION 2
C SEDATIVE THERAPY EPISTAXIS 2
C SEDATIVE THERAPY EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2
C SEDATIVE THERAPY GRAFT VERSUS HOST DISEASE IN SKIN 2
C SEDATIVE THERAPY ORAL HERPES 2
C SEDATIVE THERAPY PLEURISY 2
C SEDATIVE THERAPY PNEUMONIA 2
C SEDATIVE THERAPY PRURITUS 2
C SEDATIVE THERAPY PYREXIA 2
C SEDATIVE THERAPY RENAL FAILURE ACUTE 2
C SEDATIVE THERAPY STAPHYLOCOCCAL SEPSIS 2
C SEDATIVE THERAPY STEVENS-JOHNSON SYNDROME 2
C SEDATIVE THERAPY VOMITING 2
C SEDATIVE THERAPY WHITE BLOOD CELL COUNT DECREASED 2
C TRANSPLANT REJECTION BLOOD PRESSURE DECREASED 2
C TRANSPLANT REJECTION CHILLS 2
C TRANSPLANT REJECTION PHLEBITIS 2
C TRANSPLANT REJECTION PYREXIA 2
Ads by Google